NKTX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Nkarta (NKTX) Earnings Date & Reports

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

NKTX is expected to report earnings to rise 28.49% to -44 cents per share on May 08

Q1'25

Est.

$-0.45

Q4'24

Beat

by $0.05

Q3'24

Missed

by $0.02

Q2'24

Beat

by $0.13

Q1'24

Missed

by $0.03

The last earnings report on March 26 showed earnings per share of -34 cents, beating the estimate of -39 cents. With 709.14K shares outstanding, the current market capitalization sits at 131.27M.

View a ticker or compare two or three

Compare

NKTX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For NKTX
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a biopharmaceutical company, which engages in the discovery, development, and commercialization of natural killer cell therapies for the treatment of cancer

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

1150 Veterans Boulevard

Phone

+1 905 407-1049

Employees

150

Web

https://www.nkartatx.com